Dental device maker Align Technology's Q2 revenue slightly beats estimates
Reuters2026/07/29 20:46
Overview
US dental device maker's Q2 revenue rose 4.3% yr/yr, slightly beating analyst expectations
Adjusted EPS for Q2 beat analyst expectations
Company repurchased $67 mln in shares during the quarter
Outlook
Align expects Q3 revenue between $1.0 bln and $1.02 bln, down sequentially
Company maintains 2026 revenue growth guidance of up 3% to 4% year-over-year
Align expects Q3 gross margin to fall due to $20-$30 mln in one-time charges
Result Drivers
CLEAR ALIGNER GROWTH - Record Clear Aligner revenue and shipments, led by double-digit international growth and stable North America performance, drove overall revenue increase
SYSTEMS SERVICES DECLINE - Revenue from Imaging Systems and CAD/CAM Services fell 10.8% yr/yr due to softness in the capital equipment market and a shift toward lower-priced scanners and flexible acquisition models
FOREIGN EXCHANGE IMPACT - Foreign exchange provided a year-over-year benefit to revenue but was a sequential headwind and negatively affected margins and EPS
Company press release: ID:nBw36ZM2Wa
Key Details
Metric |
Beat/Miss |
Actual |
Consensus Estimate |
Q2 Revenue |
Slight Beat* |
$1.06 bln |
$1.05 bln (13 Analysts) |
Q2 Adjusted EPS |
Beat |
$2.64 |
$2.61 (15 Analysts) |
Q2 EPS |
|
$1.51 |
|
Q2 Adjusted Net Income |
Beat |
$189.1 mln |
$185.28 mln (12 Analysts) |
Q2 Net Income |
|
$108.3 mln |
|
Q2 Adjusted Operating Margin |
|
22.9% |
|
Q2 Gross Profit |
|
$757.43 mln |
|
*Applies to a deviation of less than 1%; not applicable for per-share numbers.
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 12 "strong buy" or "buy", 5 "hold" and 1 "sell" or "strong sell"
The average consensus recommendation for the medical equipment, supplies distribution peer group is "buy"
Wall Street's median 12-month price target for Align Technology Inc is $214.00, about 21.9% above its July 28 closing price of $175.60
The stock recently traded at 15 times the next 12-month earnings vs. a P/E of 15 three months ago
Reuters Recommended Reads
July 29 - Align Technology to overhaul board following engagement with Elliott
July 29 - Conmed Q2 sales, adjusted profit beat on organinc platform growth
July 29 - Glaukos Q2 sales jump 50%; raises net sales forecast
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
FCA lowers stablecoin capital rule to 1%, removes retail holding cap in new UK crypto framework
BNB Chain tops $3.6 billion in RWA growth, surpasses Solana in 2026
Ripple Prime acquisition boosts institutional crypto access, XRP rises 25% since August
Shiba Inu surpasses 1.8 million holders across Ethereum and Shibarium